Literature DB >> 31746407

Differentiation potential and functional properties of a CD34‑CD133+ subpopulation of endothelial progenitor cells.

Katrin Bachelier1, Carolin Bergholz1, Erik B Friedrich1.   

Abstract

Endothelial progenitor cells (EPCs) promote angiogenesis and play an important role in myocardial and vascular repair after ischemia and infarction. EPCs consist of different subpopulations including CD34CD133+ EPCs, which are precursors of more mature CD34+CD133+ EPCs and functionally more active in terms of homing and endothelial regeneration. In the present study we analyzed the functional and differentiation abilities of CD34CD133+ EPCs. Isolation of EPC populations (CD34+CD133+, CD34CD133+) were performed by specific multi‑step magnetic depletion. After specific stimulation a significant higher adhesive and migrative capacity of CD34CD133+ cells could be detected compared to CD34+CD133+ cells (P<0.001, respectively). Next to this finding, not only significantly higher rates of proliferation (P<0.005) were detected among CD34CD133+ cells, but also a higher potential of cell‑differentiation capacity into other cell types. Next to a significant increase of CD34CD133+ EPCs differentiating into a fibroblast cell‑type (P<0.001), an enhancement into a hepatocytic cell‑type (P=0.033) and a neural cell‑type (P=0.016) could be measured in contrast to CD34+CD133+ cells. On the other hand, there was no significant difference in differentiation into a cardiomyocyte cell‑type between these EPC subpopulations (P=0.053). These results demonstrate that EPC subpopulations vary in their functional abilities and, to different degrees, have the capacity to transdifferentiate into unrelated cell‑types such as fibroblasts, hepatocytes, and neurocytes. This indicates that CD34CD133+ cells are more pluripotent compared to the CD34+CD133+ EPC subset, which may have important consequences for the therapy of vascular diseases.

Entities:  

Year:  2019        PMID: 31746407     DOI: 10.3892/mmr.2019.10831

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  Regulation of endothelial progenitor cell functions during hyperglycemia: new therapeutic targets in diabetic wound healing.

Authors:  Gui Wan; Yangyang Chen; Jing Chen; Chengqi Yan; Cheng Wang; Wenqing Li; Renqun Mao; Hans-Günther Machens; Xiaofan Yang; Zhenbing Chen
Journal:  J Mol Med (Berl)       Date:  2022-01-08       Impact factor: 4.599

Review 2.  Endothelial-Mesenchymal Transition or Functional Tissue Regeneration - Two Outcomes of Heart Remodeling.

Authors:  B Šalingová; Z Červenák; A Adamičková; N Chomanicová; S Valášková; A Gažová; J Kyselovič
Journal:  Physiol Res       Date:  2021-11-30       Impact factor: 1.881

3.  Identification and characterization of a subpopulation of CD133+ cancer stem-like cells derived from SK-UT-1 cells.

Authors:  Jiuping Gao; Ting Yang; Xu Wang; Yi Zhang; Jing Wang; Beilei Zhang; Dihong Tang; Yanqiong Liu; Ting Gao; Qiuhui Lin; Jun Tang; Jingting Cai
Journal:  Cancer Cell Int       Date:  2021-03-08       Impact factor: 5.722

4.  Phase I/IIa Feasibility Trial of Autologous Quality- and Quantity-Cultured Peripheral Blood Mononuclear Cell Therapy for Non-Healing Extremity Ulcers.

Authors:  Rica Tanaka; Satoshi Fujimura; Makiko Kado; Taro Fukuta; Kayo Arita; Rie Hirano-Ito; Tomoya Mita; Hirotaka Watada; Yoshiteru Kato; Katsumi Miyauchi; Hiroshi Mizuno
Journal:  Stem Cells Transl Med       Date:  2022-03-17       Impact factor: 6.940

5.  The peripheral blood mononuclear cells versus purified CD34+ cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis-a randomized single-blinded non-inferiority trial.

Authors:  Hao Liu; Tianyue Pan; Yifan Liu; Yuan Fang; Gang Fang; Xiaolang Jiang; Bin Chen; Zheng Wei; Shiyang Gu; Peng Liu; Weiguo Fu; Zhihui Dong
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

6.  Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion.

Authors:  Hao Liu; Yuan Fang; Tianyue Pan; Gang Fang; Yifan Liu; Xiaolang Jiang; Bin Chen; Shiyang Gu; Zheng Wei; Peng Liu; Weiguo Fu; Jue Yang; Zhihui Dong
Journal:  Stem Cells Transl Med       Date:  2022-05-27       Impact factor: 7.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.